Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumorsRoman V. Uzhachenko, Anna E. Vilgelm, Vijaya Bharti et al.|Cell Reports|2021Cited by 107
Fine-Needle Aspiration-Based Patient-Derived Cancer OrganoidsAnna E. Vilgelm, Vivian Weiß, Kensey Bergdorf et al.|iScience|2020Cited by 81
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Anna E. Vilgelm, Vijay Ramani et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 22
High-throughput drug screening of fine-needle aspiration-derived cancer organoidsKensey Bergdorf, Vivian Weiß, Courtney J. Phifer et al.|STAR Protocols|2020Cited by 20
Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumorsRoman V. Uzhachenko, Anna E. Vilgelm, Vijaya Bharti et al.|Cell Reports|2021Cited by 18